The Clinical Significance of Staphylococcus aureus Small Colony Variants

Lab Med. 2023 May 2;54(3):227-234. doi: 10.1093/labmed/lmac101.

Abstract

A burdensome, atypical phenotype of Staphylococcus aureus (SA) called S aureus small colony variant (SA-SCV) has been identified, which is induced as a result of a combination of environmental stressors, including polymicrobial interactions. The SA-SCVs exhibit altered phenotypes as a result of metabolic dormancy caused by electron transport deficiency, leading to increased biofilm production and alterations to antimicrobial susceptibility. The SA-SCVs typically exhibit altered colony morphology and biochemical reactions compared with wild-type SA, making them difficult to detect via routine diagnostics. The SA-SCVs have been found to contribute to chronic or recurrent infections, including skin and soft-tissue infections, foreign-body associated infection, cystic fibrosis, and sepsis. There is evidence that SA-SCVs contribute to patient morbidity and mortality as a result of diagnostic difficulties and limited treatment options. New detection methods may need to be developed that can be incorporated into routine diagnostics, which would allow for better assessment of specimens and introduce new considerations for treatment.

Keywords: Staphylococcus aureus; Staphylococcus aureus small colony variants; antimicrobial resistance; antimicrobial susceptibility; chronic infections; diagnostics.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Clinical Relevance
  • Humans
  • Staphylococcal Infections* / diagnosis
  • Staphylococcal Infections* / drug therapy
  • Staphylococcus aureus* / genetics
  • Staphylococcus aureus* / metabolism

Substances

  • Anti-Bacterial Agents